Global Oral Cancer Clinical Trials Insights H1, 2020 by Trial Status, Trial Phase, Sponsor Type, End Point Status, Region and Country

DUBLIN, March 18, 2020 /PRNewswire/ -- The "Oral Cancer Clinical Trials Review H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

This clinical trial report, Oral Cancer Clinical Trials Review H1, 2020 provides an overview of Oral Cancer Clinical trials scenario.

This report provides top line data relating to the clinical trials on Oral Cancer. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Report Scope

• The report provides a snapshot of the global clinical trials landscape
• It provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The study reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The teport provides enrollment trends for the past five years
• It also provides the latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered

Companies Mentioned

• Bristol-Myers Squibb Co.
• AstraZeneca PLC
• Merck & Co. Inc.
• Amgen Inc.
• F. Hoffmann-La Roche Ltd.
• Pfizer Inc.
• Sanofi
• E. Merck KG
• Astellas Pharma Inc.
• C. H. Boehringer Sohn AG & Co KG

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/25z92d

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-oral-cancer-clinical-trials-insights-h1-2020-by-trial-status-trial-phase-sponsor-type-end-point-status-region-and-country-301026239.html

SOURCE Research and Markets